ATE408614T1 - Neue macrolide mit antibakterieller wirkung - Google Patents

Neue macrolide mit antibakterieller wirkung

Info

Publication number
ATE408614T1
ATE408614T1 AT01960680T AT01960680T ATE408614T1 AT E408614 T1 ATE408614 T1 AT E408614T1 AT 01960680 T AT01960680 T AT 01960680T AT 01960680 T AT01960680 T AT 01960680T AT E408614 T1 ATE408614 T1 AT E408614T1
Authority
AT
Austria
Prior art keywords
antibacterial effect
new macrolides
heterocyclyl
hydrogen
formula
Prior art date
Application number
AT01960680T
Other languages
German (de)
English (en)
Inventor
Peter Angehrn
Daniel Hunziker
Pierre-Charles Wyss
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Application granted granted Critical
Publication of ATE408614T1 publication Critical patent/ATE408614T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT01960680T 2000-08-22 2001-08-20 Neue macrolide mit antibakterieller wirkung ATE408614T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00117971 2000-08-22

Publications (1)

Publication Number Publication Date
ATE408614T1 true ATE408614T1 (de) 2008-10-15

Family

ID=8169600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01960680T ATE408614T1 (de) 2000-08-22 2001-08-20 Neue macrolide mit antibakterieller wirkung

Country Status (14)

Country Link
US (1) US6740642B2 (enExample)
EP (1) EP1313751B1 (enExample)
JP (1) JP4162992B2 (enExample)
KR (1) KR100502031B1 (enExample)
CN (1) CN1234718C (enExample)
AT (1) ATE408614T1 (enExample)
AU (1) AU2001282105A1 (enExample)
BR (1) BR0113472A (enExample)
CA (1) CA2419296C (enExample)
DE (1) DE60135859D1 (enExample)
ES (1) ES2313975T3 (enExample)
MX (1) MXPA03001607A (enExample)
WO (1) WO2002016380A1 (enExample)
ZA (1) ZA200301047B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2275621T3 (es) * 2000-12-21 2007-06-16 Glaxo Group Limited Antibioticos macrolidos.
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
CN1589277A (zh) * 2001-09-17 2005-03-02 奥索-麦克尼尔药品公司 6－o－氨基甲酸酯－11,12－内酯－酮内酯抗菌剂
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) * 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
US6720308B1 (en) 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
US6716820B1 (en) 2003-06-05 2004-04-06 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic macrolides
US20040254126A1 (en) * 2003-06-05 2004-12-16 Yao-Ling Qiu 11-12 Bicyclic erythromycin derivatives
US6790835B1 (en) 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US6774115B1 (en) 2003-06-05 2004-08-10 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic ketolides
WO2004108745A2 (en) * 2003-06-05 2004-12-16 Enanta Pharmaceuticals, Inc. 11-12 bicyclic erythromycin derivatives
US6765016B1 (en) 2003-06-05 2004-07-20 Enanta Pharmaceuticals, Inc. Bicyclic ketolide derivatives
WO2006065721A2 (en) * 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
DE602006006030D1 (de) * 2005-02-09 2009-05-14 Basilea Pharmaceutica Ag Neue makrolide
CN101115764B (zh) * 2005-02-09 2012-09-26 巴斯利尔药物股份公司 大环内酯类化合物
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
JP2009506066A (ja) 2005-08-24 2009-02-12 リブ−エックス ファーマシューティカルズ，インコーポレイテッド トリアゾール化合物ならびにこれを作製する方法および使用する方法
PT2049556E (pt) * 2006-08-09 2013-08-22 Basilea Pharmaceutica Ag Novos macrólidos úteis contra doenças inflamatórias e alérgicas
EP2056844A4 (en) * 2006-08-24 2010-11-24 Wockhardt Research Center NEW MACROLIDS AND KETOLIDS WITH ANTIMICROBIAL EFFECT
CN101939327B (zh) * 2008-02-08 2015-03-11 巴斯利尔药物股份公司 新的大环内酯类及其用途
JP5769972B2 (ja) * 2008-02-08 2015-08-26 バジリア ファルマスーチカ アーゲーＢａｓｉｌｅａ Ｐｈａｒｍａｃｅｕｔｉｃａ ＡＧ Ｐｄｅ阻害により仲介される疾患を処置するためのマクロライド
RU2011153353A (ru) * 2009-05-27 2013-07-10 Вокхардт Рисерч Сентер Кетолидные соединения, обладающие противомикробной активностью
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
CN102417530A (zh) * 2010-09-26 2012-04-18 中国医学科学院药物研究所 广谱抗菌素红霉素a大环酮内酯类衍生物的合成方法和用途
EP3216798A3 (en) 2010-12-09 2017-10-25 Wockhardt Limited Ketolide compounds
US9206214B2 (en) 2011-03-01 2015-12-08 Wockhardt Ltd. Process for preparation of ketolide intermediates
PL2938623T3 (pl) * 2012-12-31 2017-03-31 Basilea Pharmaceutica Ag Wybrane makrolidy o działaniu hamującym pde4
US10857171B2 (en) 2016-01-12 2020-12-08 Wockhardt Limited Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
DE60135859D1 (de) 2008-10-30
AU2001282105A1 (en) 2002-03-04
MXPA03001607A (es) 2003-06-04
EP1313751A1 (en) 2003-05-28
CN1234718C (zh) 2006-01-04
CA2419296C (en) 2008-12-09
ES2313975T3 (es) 2009-03-16
JP2004506740A (ja) 2004-03-04
CA2419296A1 (en) 2002-02-28
KR20030029839A (ko) 2003-04-16
KR100502031B1 (ko) 2005-07-25
WO2002016380A1 (en) 2002-02-28
US20030199459A1 (en) 2003-10-23
JP4162992B2 (ja) 2008-10-08
BR0113472A (pt) 2003-07-01
ZA200301047B (en) 2004-05-06
US6740642B2 (en) 2004-05-25
EP1313751B1 (en) 2008-09-17
CN1464880A (zh) 2003-12-31

Similar Documents

Publication Publication Date Title
DE60135859D1 (de) Neue macrolide mit antibakterieller wirkung
FR2742757B1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FI923691A0 (fi) Cykliska iminoderivat, dessa foereningar innehaollande farmaceutiska blandningar och foerfarande foer deras framstaellning.
NO991700L (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
FI915136A0 (fi) Cykliska iminoderivat, dessa foereningar innehaollande laekemede och foerfarande foer deras framstaellning.
EP1256588A4 (en) NEW PYRAZINE DERIVATIVES OR SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THE DERIVATIVES OR THEIR SALTS AND INTERMEDIATES FOR BOTH PRODUCTION
EA200400536A1 (ru) Макролиды
CA2476884A1 (en) Macrolides with antibacterial activity
DE69920362D1 (de) Neue Makrolidderivate
DE69400817D1 (de) 9a-N-(N'-Carbamoyl)-und 9a-N-(N'Thiocarbamoyl)-Derivate von 9-Deoxo-9a-aza-9a-homoerythromycin A
DE60333546D1 (de) PyrazoloÄ4,3-DÜpyrimidines, verfahren zur ihre herstellung und deren verwendung
FR2804958B1 (fr) Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
BR9807795A (pt) Derivados da eritromicina, seu processo de preparo e sua aplicação como medicamentos
ATE244258T1 (de) Halo-derivate von 9-deoxo-9a-aza-9a- homerythromycin a
ES2100177T3 (es) Compuestos de cefalosporina y su produccion.
DE69812059D1 (de) Beta,beta-disubstituierte Derivate von 9-Deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A
PT1575969E (pt) Derivados com substituicao 9a-n- (n'-4- ( sulfonil )fenil ) carbamoilo ) de 9-desoxo-9-dihidro-9a-aza-9a-homoeritromicina a e 5-0-desosaminil-9-desoxo-9-di-hidro-9a-aza-9a-homoeritronilida a
MXPA05006220A (es) Nuevos antibioticos macrolidos semisinteticos de la serie de azalidas.
EP0254582A3 (en) 6 beta-(alpha-oximino)-acylamino penicillanic-acid derivatives and starting compounds
TH14271B (th) อนุพันธ์อีริโธรไมซินชนิดใหม่ กรรมวิธีการเตรียม และการใช้ประโยชน์เป็นยา

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee